ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 387 filers reported holding ENCOMPASS HEALTH CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $20,556,000 | +2.0% | 263,432 | +7.1% | 0.05% | -2.0% |
Q1 2021 | $20,154,000 | -1.1% | 246,077 | -0.1% | 0.05% | -5.6% |
Q4 2020 | $20,375,000 | +23.7% | 246,400 | -2.8% | 0.05% | +1.9% |
Q3 2020 | $16,466,000 | +1.1% | 253,394 | -3.6% | 0.05% | -7.0% |
Q2 2020 | $16,281,000 | -4.4% | 262,894 | -1.1% | 0.06% | -24.0% |
Q1 2020 | $17,025,000 | -2.0% | 265,886 | +6.0% | 0.08% | +29.3% |
Q4 2019 | $17,369,000 | -16.7% | 250,746 | -23.9% | 0.06% | -18.3% |
Q3 2019 | $20,847,000 | -55.1% | 329,440 | -55.1% | 0.07% | -53.0% |
Q2 2019 | $46,457,000 | -38.0% | 733,225 | -42.9% | 0.15% | -39.6% |
Q1 2019 | $74,988,000 | +2.1% | 1,284,042 | +7.8% | 0.25% | -6.7% |
Q4 2018 | $73,464,000 | -25.8% | 1,190,662 | -6.2% | 0.27% | -2.2% |
Q3 2018 | $98,968,000 | -15.5% | 1,269,632 | -26.6% | 0.27% | -19.9% |
Q2 2018 | $117,150,000 | +0.8% | 1,729,918 | -14.9% | 0.34% | -0.9% |
Q1 2018 | $116,238,000 | – | 2,033,203 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |